WOBURN, Mass. , Sept. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc. (Nasdaq: NURO) today reported the launch of the Quell Watch App , now available for download from the Apple App store. The Quell Watch app gives a Quell user the ability to control and monitor their pain relief from their Apple
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced the launch of a new website to promote Quell ® , the company's rapidly growing pain relief brand. The new site reflects NeuroMetrix' focus on helping people with chronic pain reclaim their lives.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced a pre-order campaign on the world's largest crowdfunding platform, Indiegogo. With the campaign that begins March 2 , consumers and healthcare professionals will have the ability to purchase Quell Wearable Pain Relief
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today reported the commercial launch of DPNCheck in Mexico . The initial DPNCheck order will be utilized by one of Mexico's six major government healthcare institutions to improve the detection of diabetic neuropathy and advance the
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO) reported today the Quell ® app is now available in Google Play. Quell is an over-the-counter wearable pain relief device that utilizes proprietary non-invasive neurostimulation technology to provide relief from chronic pain.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care diagnostics that helps patients and physicians better manage chronic pain, nerve disorders, and associated sleep
Early adopters come together to dialog with the makers of the Quell wearable technology. WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) held its first Quell ® Wearable Pain Relief Technology™ user event last Thursday, April 27 . As a customer-focused company, NeuroMetrix
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO), reported that Quell was featured on ABC's Good Morning America on September 17 in a segment titled " Erase Your Pain ". Good Morning America is the #1 morning show in the US, reaching nearly 5 million households each week.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported increased media attention in 2017 on the company's Quell ® Wearable Pain Relief Technology™. An Inside Look at the Latest Health Tech - The Dr. Oz Show 3 Amazing New Gadgets to Relieve Aches & Pains - Fox News Could this
